scPharmaceuticals Inc.
3.54
0.16 (4.73%)
At close: Jan 15, 2025, 2:26 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -4.41 -5.42 -4.5 -3.78 -3.06 -2.37 -1.5 -6.48 -15.02
PS Ratio 17.77 n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 6.49 -0.9 -0.72 -0.8 -0.81 -0.72 0.34 -4.26 -8.66
P/FCF Ratio -4.07 -5.88 -5.06 -4.69 -3.46 -2.42 -1.57 -10.21 -16.36
P/OCF Ratio -4.08 -5.88 -5.06 -4.69 -3.46 -2.42 -1.58 -10.22 -16.38
OCF/S Ratio -4.36 n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 1.08 -0.16 -0.09 -0.12 -0.16 -0.12 0.11 n/a n/a
Quick Ratio 6.40 16.46 5.27 11.57 13.98 13.53 22.85 10.61 0.84
Current Ratio 7.08 16.63 5.27 11.57 14.44 13.77 23.01 10.64 0.91
Asset Turnover 0.14 n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -6.82 -10.95 -10.03 -11.57 -18.62 -20.72 -29.41 -2.75 n/a
Return on Equity (ROE) -1.47 0.17 0.16 0.21 0.27 0.31 -0.22 0.66 0.58
Return on Assets (ROA) -0.58 -0.3 -0.39 -0.32 -0.45 -0.31 -0.2 -0.61 -5.7
Return on Capital (ROIC) -0.68 -0.31 -0.4 -0.3 -0.46 -0.34 -0.2 -0.5 68.20
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 71.96% n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin -403.22% n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -403.22% n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin -407.53% n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin -436.14% n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin -338.86% n/a n/a n/a n/a n/a n/a n/a n/a